J&J Wins Jury Verdict Vs. Boston Scientific In Patent Suit Over Drug-Coated Stent
Johnson & Johnson is emerging triumphantly from its patent litigation against its rivals in the highly lucrative market for drug-eluting stents, winning a second major victory this month in a jury...To view the full article, register now.
Already a subscriber? Click here to view full article